Why Is AMD Trading Higher?
Advanced Micro Devices, Inc (NASDAQ:AMD) shares are trading higher, moving in sympathy with Marvell Technology Inc (NASDAQ:MRVL), following Marvell’s strong first quarter results and its forecast that AI revenue w
10 Stocks Reacting To April PCE: Marvell Technology Leads The Rally
The U.S. Bureau of Economic Analysis issued data Friday showing the Personal Consumption Expenditure (PCE) price index, the…
Amended European Deal For BioNTech-Pfizer’s Covid-19 Vaccines Allows Reduced Purchases
The European Commission (EC) had agreed with BioNTech SE (NASDAQ:BNTX) and Pfizer Inc (NYSE:PFE) on adapting the existing contract on vaccines against Covid-19, including…
Regeneron Reveals Updated Data From Multiple Myeloma Study, Showing Response Rate Of 71%
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced updated data from two Phase 2 expansion dose cohorts of linvoseltamab (formerly REGN5458) in…
AstraZeneca/Merck’s Cancer Drug Combo Shows Positive Results In Endometrial Cancer
AstraZeneca Plc’s (NASDAQ:AZN) combination of Imfinzi (durvalumab) and Lynparza (olaparib), when added to platinum-based chemotherapy, showed positive results in the DUO-E…
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
Merck & Co Inc (NYSE:MRK) announced data from the final pre-specified overall survival (OS) analysis of the pivotal Phase…
Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech’s Vengeance Over 2022’s Rate-Hike-Induced Market Fall
Value stocks fell to a seven-month low in relation to growth stocks, already lagging by more than 20% year to date on the heels of an AI-related rally propelling equities in the technology sector.
One First Republic Employee Was Making More Than Jamie Dimon, Others Were Taking Home Eye-Watering Amounts
In the wake of the collapse of First Republic Bank, eye-popping details about the compensation of its employees…
BioNTech’s Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China’s Rising XBB1.5 Cases
In an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains in line with recommendations by the World Health Organization.
Bud Light Said It’ll Buy Back Expired Beer In Wake Of Boycott
Anheuser-Busch Inbev SA’s (NYSE:BUD) Bud Light pledged to buy back its own expired beer from wholesalers in response…